Pharmaceutical Outsourcing Q3 2023 - 33

TUESDAY, OCTOBER 24
Begin the second full day of PharmSci 360
with a choice of symposia. " Advanced
Modelling and Predictive Approaches in Drug
Development, Manufacturing and Analysis "
includes presentations exploring AI and machine
learning, continuous manufacturing, deep
learning models, and digital twins. " Enabling
Excipients and Approaches for Advancing
Formulation and Delivery " examines new
approaches to formulation.
The symposia " Harnessing the Power of AI/ML
in Drug Development " promises to be a " can't
miss " session with a presentation diving into the
current regulatory environment.
Afternoon keynotes address twenty-first century
excipient taxonomy, long-acting injectable
formulations, and use of process modeling
and digital twins for monoclonal antibody
bioprocessing.
Don't miss the Speaker Spotlight from USP's
Catherine Sheehan! She provides information on
USP excipient standards.
End the day by attending a Hot Topic panel on
ICH M10 which was published in May 2022.
WEDNESDAY, OCTOBER 25
On the final day of PharmSci 360, participate
once again in a selection of symposia. " Novel
Modalities and Cross-Modality Considerations in
Manufacturing and Analysis " features
presentations on regulatory requirements
for extractables and leachables testing in
combination products, statistical methods,
and submicron particles. " The Bioanalytical
Lab of the Future " examines metabolomics,
biomarkers, assays for cell and gene therapies,
and proteomics.
Fernando Muzzio, Ph.D., of Rutgers, The State
University of New Jersey, offers insights into the
future of advanced manufacturing in a Speaker
Spotlight.
Can't get enough on AI and machine learning?
A Hot Topic panel Wednesday afternoon
features discussion on the data requirements
of AI and machine learning during preclinical
development.
After a busy threeand-a-half
days, Julie
DeMartino, Ph.D., closes
out PharmSci 360. She
is the founder and CEO
of AcheneRx, a pharma
consulting firm focusing
on drug discovery and
development of novel treatments for debilitating
and progressive diseases.
Before you leave, join us for the Closing
Reception from 5:30 pm to 6:30 pm and say
farewell to your colleagues and your new
industry connections.
In addition to these sessions, each full day includes career development resources,
Rapid Fire presentations and opportunities to visit poster presentations.
FOR MORE INFORMATION and
to access the full program, visit
www.aaps.org/pharmsci360.
http://www.aaps.org/pharmsci360
Pharmaceutical Outsourcing Q3 2023

Table of Contents for the Digital Edition of Pharmaceutical Outsourcing Q3 2023
